Although the immunomodulatory role of B7-H3 in canine cancers still needs to be defined, we sought to discern whether soluble B7-H3 in melanoma-derived SEVs could be detected and potentially used as a prognostic biomarker for OMM. This evidence concerns the gene CD276 and melanoma.